Literature DB >> 16013637

The value of ultrasonography and computerized tomography in estimating the histopathological severity of nonalcoholic steatohepatitis.

H Ataseven1, M H Yildirim, M Yalniz, I H Bahcecioglu, S Celebi, I H Ozercan.   

Abstract

BACKGROUND & AIMS: Liver biopsy is the gold standard for the diagnosis of non-alcoholic steatohepatitis (NASH), but is an invasive method. There is a need for non-invasive methods that can reflect the histopathological severity of NASH. The aim of this study was to compare the ultrasonography and computerized tomography findings with the histopathological severity in patients with NASH.
MATERIAL AND METHODS: Twenty-two consecutive patients with biopsy proven NASH and 20 age- and sex-matched healthy individuals were enrolled. Clinical and demographic data were collected at the time of liver biopsy. Histopathological grading and staging were made by an expert pathologist. Each patient underwent ultrasonography and computerized tomography.
RESULTS: Liver ultrasonographic findings were not correlated with histopathological grade and stage (r: 0.134, P > 0.05; r: 0.130, P > 0.05). Mean liver densities obtained by computed tomography of NASH patients were lower than that of controls (P < 0.05) and liver/spleen density ratios were lower than that of controls (P < 0.05). These results were significantly correlated with histopathological grade (r: -0.716, P < 0.001; r: -0.663, P: 0.001), but not with the histopathologic stage (r: -0.416, P: 0.05; r: -0.356, P: 0.1).
CONCLUSIONS: Ultrasonography findings do not reflect histopathological severity in patients with NASH. Computed tomography attenuation of the liver is significantly correlated with histopathologic grade but not with histopathological stage.

Entities:  

Mesh:

Year:  2005        PMID: 16013637

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  6 in total

1.  Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study.

Authors:  Ryan L McKimmie; Kurt R Daniel; J Jeffrey Carr; Donald W Bowden; Barry I Freedman; Thomas C Register; Fang-Chi Hsu; Kurt K Lohman; Richard B Weinberg; Lynne E Wagenknecht
Journal:  Am J Gastroenterol       Date:  2008-10-03       Impact factor: 10.864

Review 2.  Hypertension and hepatic steatosis.

Authors:  Matthew J Brookes; Tariq H Iqbal; Brian T Cooper
Journal:  Curr Hypertens Rep       Date:  2008-06       Impact factor: 5.369

3.  Non-alcoholic Steatohepatitis in a Sample of Iranian Adult Population: Age is a Risk Factor.

Authors:  Mehran Rogha; Nazila Najafi; Azadeh Azari; Mahboubeh Kaji; Zahra Pourmoghaddas; Fereshteh Rajabi; Mina Rezaee
Journal:  Int J Prev Med       Date:  2011-01

4.  Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease.

Authors:  M S Mirza
Journal:  ISRN Gastroenterol       Date:  2011-08-28

5.  Comparative accuracy of CT, dual-echo MRI and MR spectroscopy for preoperative liver fat quantification in living related liver donors.

Authors:  Ruchi Rastogi; Subhash Gupta; Bhavya Garg; Sandeep Vohra; Manav Wadhawan; Harsh Rastogi
Journal:  Indian J Radiol Imaging       Date:  2016 Jan-Mar

6.  Chia (Salvia hispanica)-supplemented diet ameliorates non-alcoholic fatty liver disease and its metabolic abnormalities in humans.

Authors:  Aida Medina-Urrutia; Angel R Lopez-Uribe; Mohamed El Hafidi; Maria Del Carmen González-Salazar; Rosalinda Posadas-Sánchez; Esteban Jorge-Galarza; Leonardo Del Valle-Mondragón; Juan G Juárez-Rojas
Journal:  Lipids Health Dis       Date:  2020-05-19       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.